Abstract:Research into major depressive disorder (MDD) is complicated by population heterogeneity, which has motivated the search for more homogeneous subtypes through data-driven computational methods to identify patterns in data. In addition, data on biological differences could play an important role in identifying clinically useful subtypes. This systematic review aimed to summarize evidence for biological subtypes of MDD from data-driven studies. We undertook a systematic literature search of PubMed, PsycINFO, and Embase (December 2018). We included studies that identified (1) data-driven subtypes of MDD based on biological variables, or (2) data-driven subtypes based on clinical features (e.g., symptom patterns) and validated these with biological variables post-hoc. Twenty-nine publications including 24 separate analyses in 20 unique samples were identified, including a total of ~ 4000 subjects. Five out of six biochemical studies indicated that there might be depression subtypes with and without disturbed neurotransmitter levels, and one indicated there might be an inflammatory subtype. Seven symptom-based studies identified subtypes, which were mainly determined by severity and by weight gain vs. loss. Two studies compared subtypes based on medication response. These symptom-based subtypes were associated with differences in biomarker profiles and functional connectivity, but results have not sufficiently been replicated. Four out of five neuroimaging studies found evidence for groups with structural and connectivity differences, but results were inconsistent. The single genetic study found a subtype with a distinct pattern of SNPs, but this subtype has not been replicated in an independent test sample. One study combining all aforementioned types of data discovered a subtypes with different levels of functional connectivity, childhood abuse, and treatment response, but the sample size was small. Although the reviewed work provides many leads for future research, the methodological differences across studies and lack of replication preclude definitive conclusions about the existence of clinically useful and generalizable biological subtypes.

Biological heterogeneity of melancholia: Results of pattern recognition methods

A clinical and biological validation of the DSM-III melancholia diagnosis in men: Results of pattern recognition methods

Circulating T-cell Subsets Discrepancy Between Bipolar Disorder and Major Depressive Disorder During Mood Episodes: A Naturalistic, Retrospective Study of 1015 Cases

Clinical Subtypes of Unipolar Depression: Part III. Quantitative Differences in Various Biological Markers Between the Cluster-Analytically Generated Nonvital and Vital Depression Classes

Heterogeneity of amygdala response in major depressive disorder: the impact of lifetime subthreshold mania

A Multivariate Study of Simultaneous Escape from Suppression by Dexamethasone of Urinary Free Cortisol, Plasma Cortisol, Adrenocorticotropic Hormone and Beta-Endorphin in Melancholic Patients.

Cluster Analytic Validation of the DSM Melancholic Depression. the Threshold Model: Integration of Quantitative and Qualitative Distinctions Between Unipolar Depressive Subtypes

Dissection of depression heterogeneity using proteomic clusters

Data-driven biological subtypes of depression: systematic review of biological approaches to depression subtyping

Biotypes of major depressive disorder: Neuroimaging evidence from resting-state default mode network patterns.

Symptom Profiles of Biological Markers in Depression: a Multivariate Study.

Shared and distinct homotopic connectivity changes in melancholic and non-melancholic depression

Markers of positive affect and brain state synchrony discriminate melancholic from non-melancholic depression using naturalistic stimuli

Abnormal Default-Mode Network Homogeneity in Melancholic and Nonmelancholic Major Depressive Disorder at Rest

Major depressive disorder with melancholia displays robust alterations in resting state heart rate and its variability: implications for future morbidity and mortality

Disturbances in Acute Phase Plasma Proteins During Melancholia: Additional Evidence for the Presence of an Inflammatory Process During That Illness

Disrupted Regional Homogeneity in Melancholic and Non-melancholic Major Depressive Disorder at Rest

Differences in Neurobiology of Different Syndrome of Melancholia in the Viewpoint of TCM

More Alike than Different: Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder across Neuroimaging Modalities

Aberrant Default Mode Network Homogeneity in Patients with First-Episode Treatment-Naive Melancholic Depression.

Identifying melancholic depression biomarker using whole-brain functional connectivity